PATHOLOGICAL FEAR OF NEEDLES HOW TO
PATHOLOGICAL FEAR OF NEEDLES REGISTRATION
PATHOLOGICAL FEAR OF NEEDLES SOFTWARE

RA is more common in women, and the risk of RA in women is about 3 times higher than that in men. In the United States, the annual loss caused by RA is more than $1 billion.

According to 2010 data, the prevalence of RA accounts with 0.24% of the global population. It is a chronic autoimmune disease characterized by symmetrical, persistent synovitis and destructive polyarthritis. Rheumatoid arthritis (RA) is the most common inflammatory arthritis.

PATHOLOGICAL FEAR OF NEEDLES REGISTRATION

OSF Registration number: DOI 10.17605/OSF.IO/4X5QB The results of this study will provide a reliable reference for the clinical use of a silver needle in the treatment of rheumatoid arthritis. This study will evaluate the clinical efficacy of a silver needle in the treatment of rheumatoid arthritis.

PATHOLOGICAL FEAR OF NEEDLES SOFTWARE

Data will be analyzed using the statistical software package SPSS version 18.0 (Chicago, IL). Observation indicators include: TCM symptom score, HAQDI score, DAS-28 score, laboratory indicators, adverse reactions and so on. The patients are followed up for 2 months after 4 weeks of treatment. The patients are randomly divided into a treatment group (silver needle treatment group) or control group (routine western medicine treatment group). Approved by the Clinical Research Ethics Committee of our hospital. This is a prospective randomized controlled trial to study the efficacy and safety of silver needles in the treatment of rheumatoid arthritis. The evidence shows that silver needle therapy has advantages in the treatment of rheumatoid arthritis, but there is a lack of standard clinical studies to verify this conclusion. Therefore, complementary and alternative therapies need to be explored. Adverse reactions and drug resistance associated with conventional treatment can no longer meet the clinical need. Rheumatoid arthritis is a kind of chronic crippling disease, the condition is complex, the course of the disease is repeated, seriously affecting the quality of life of patients. This is an open access article distributed under the Creative Commons Attribution License 4.0 (CCBY), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. Patient consent: Informed consent has been obtained from the patient and approval has been obtained from the ethics committee.Įthics: This study has been approved by the Ethics committee.ĭata sharing not applicable to this article as no datasets were generated or analyzed during the current study. The authors have no conflicts of interest to disclose.

This work is supported by the 2019 Institute scientific research project (No.2019009) The efficacy and safety of silver needle in the treatment of rheumatoid arthritis: A protocol of randomized controlled trial.

PATHOLOGICAL FEAR OF NEEDLES HOW TO

How to cite this article: Yu J, Wang P, Nie C, Zheng B.

∗Correspondence: Bo Zheng, No.98 Ulanbuhe Road, Linhe District, Bayannur City, Inner Mongolia 015000, China (e-mail: ).Ībbreviations: CONSORT = Consolidated Standards of Reporting Trials, RCT = Randomized controlled trial, RA = Rheumatoid arthritis, ACR = American College of Rheumatology, EULAR = European League Against Rheumatism. Bayannur City Hospital, Inner Mongolia 015000, China.

Pathological fear of needles